H

HCAT

HCAT

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
5%Bearish
Buy/Sell Ratio7% buys
BearishBullish
HCAT Live QuoteReal-time
$1.29
$0.45(-25.86%)1M
Day Range$1.29 – $1.40
Open$1.29
Previous Close$1.29
Volume442.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$98.24M
P/E Ratio (TTM)24.5
Forward P/E10.0
EPS (TTM)$-2.80
Price to Book0.7
Dividend Yield0.65%
Beta (Volatility)1.51
IndustryHEALTH INFORMATION SERVICES
52-Week RangeCurrent: $1.29 (16%)
Low: $0.95High: $3.02
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$1.77-98.8% upside

Insider Buys

1

$105K

Insider Sales

23

$1.46M

Total Volume

$1.56M

47 transactions

Net Activity

$1.35M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
50CONFIDENCE

Sentiment Rating

Neutral / Balanced

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Heavy distribution: sales represent 93% of total transaction value.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys23 sells

$168.53B total

L
2

Landry Benjamin

GC

0 buys7 sells

$500K total

L
3

Lesueur Daniel

COO

0 buys7 sells

$404K total

A
4

Alger Jason

CFO

0 buys1 sells

$163K total

L
5

Llewelyn Linda

Chief People Officer

0 buys4 sells

$135K total

Trading History
HCAT insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 11, 2026

1 weeks ago

Landry Benjamin

GC

General Counsel
Sell99.5K$1.42$141K

Sep 14, 2026

2 months ago

Kohl Simeon

CEO

CEO
Buy59.0K$1.79$105K

Sep 14, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.86M$59000.00$168.53B

Dec 4, 2025

11 months ago

Larson-Green Julie

Dir

Director
Sell48.0K$2.67$128K

Dec 4, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell73.6K$-47997.00$0

Dec 5, 2025

11 months ago

Landry Benjamin

GC

General Counsel
Sell27.4K$2.64$72K

Dec 5, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell100.0K$-27425.00$0

Sep 5, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell141.8K$-6175.00$0

Sep 5, 2025

14 months ago

Landry Benjamin

GC

General Counsel
Sell6.2K$3.35$21K

Jun 5, 2025

17 months ago

Landry Benjamin

GC

General Counsel
Sell6.1K$3.94$24K

Jun 5, 2025

17 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell151.1K$-6057.00$0

May 5, 2025

18 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell205.8K$-5209.00$0

May 5, 2025

18 months ago

Lesueur Daniel

COO

COO
Sell5.2K$4.10$21K

Apr 3, 2025

19 months ago

Lesueur Daniel

COO

COO
Sell5.2K$4.15$22K

Apr 3, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell211.0K$-5209.00$0

Mar 6, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell160.4K$-13827.00$0

Mar 5, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell216.3K$-16902.00$0

Mar 5, 2025

20 months ago

Lesueur Daniel

COO

COO
Sell16.9K$4.52$76K

Mar 6, 2025

20 months ago

Landry Benjamin

GC

General Counsel
Sell13.8K$4.55$63K

Feb 18, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell85.8K$-6441.00$0

Feb 18, 2025

21 months ago

Llewelyn Linda

Chief People Officer

C-Level
Sell6.4K$5.43$35K

Feb 5, 2025

21 months ago

Lesueur Daniel

COO

COO
Sell5.2K$5.76$30K

Feb 5, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell86.0K$-5209.00$0

Jan 15, 2025

22 months ago

Llewelyn Linda

Chief People Officer

C-Level
Sell6.4K$5.80$37K

Jan 15, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell92.3K$-6442.00$0

Jan 6, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell91.3K$-5209.00$0

Jan 6, 2025

22 months ago

Lesueur Daniel

COO

COO
Sell5.2K$7.51$39K

Jan 6, 2025

22 months ago

Landry Benjamin

GC

General Counsel
Sell2.5K$7.52$19K

Dec 30, 2024

23 months ago

Gallagher Duncan

Dir

Director
Sell4.5K$6.93$31K

Dec 30, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell69.9K$-4500.00$0

Dec 23, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell74.4K$-4500.00$0

Dec 23, 2024

23 months ago

Gallagher Duncan

Dir

Director
Sell4.5K$6.98$31K

Dec 16, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell98.7K$-6442.00$0

Dec 16, 2024

23 months ago

Llewelyn Linda

Chief People Officer

C-Level
Sell6.4K$7.88$51K

Dec 6, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell86.7K$-19599.00$0

Dec 6, 2024

23 months ago

Landry Benjamin

GC

General Counsel
Sell19.3K$8.32$160K

Dec 6, 2024

23 months ago

Alger Jason

CFO

CFO
Sell19.6K$8.32$163K

Dec 4, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell96.5K$-22773.00$0

Dec 4, 2024

23 months ago

Lesueur Daniel

COO

COO
Sell22.8K$7.70$175K

Dec 2, 2024

23 months ago

Freeman Kevin Lee

Chief Commercial Officer

C-Level
Sell7.5K$8.94$67K

Dec 2, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell236.9K$-7500.00$0

Nov 15, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell112.9K$-1365.00$0

Nov 15, 2024

24 months ago

Llewelyn Linda

Chief People Officer

C-Level
Sell1.4K$8.50$12K

Nov 5, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell129.7K$-5209.00$0

Nov 5, 2024

24 months ago

Lesueur Daniel

COO

COO
Sell5.2K$7.70$40K

Oct 15, 2024

25 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell114.3K$-1324.00$0

Oct 3, 2024

25 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell134.9K$-5209.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
HCAT Buy Conviction7%
Industry Rank#455 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

HCAT has an insider buy conviction of 7%, compared to the Unknown sector buy average of 6%. HCAT ranks #455 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for HCAT

Over the last 90 days, corporate insiders at HCAT (HCAT) engaged in a total of 47 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 23 were sales. The total volume of insider trading reached $1.56M.

The net insider activity for HCAT shows a net selling bias of $1.35M. This activity represents a 7% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 2.86M shares valued at $168.53B on Sep 14, 2026.

Live Market News & Developments
Aggregated real-time headlines for HCAT (HCAT)
6 updates

Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks

Yahoo Finance61d ago

HCAT - Health Catalyst Inc Stock Price and Quote

Finviz177d ago

Health Catalyst (HCAT) Stock Trades Up, Here Is Why

Yahoo Finance188d ago

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

StockStory104d ago

Health Catalyst (HCAT) Stock Price Sinks On Margin Reset Fears

Simply Wall St103d ago

SoundHound AI, Health Catalyst, and Toast shares are falling, what you need to know

The Globe and Mail9d ago

FAQs About HCAT Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for HCAT.

Based on SEC Form 4 disclosures, the Insider Confidence Score for HCAT is currently 50/100, which reflects a neutral / balanced bias. This calculation accounts for a total of 1 purchases and 23 sales by company executives over the last 90 days.

The CEO Conviction Index for HCAT is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.